Benign Liver Lesions - Diagnosis and Treatment
A liver lesion found on an ultrasound or CT scan can sound alarming, but many are benign, common, and need little more than careful identification. The key is to work out what the lesion is, rather than to rush into treatment.
In most cases, ultrasound, CT, and MRI can make a confident diagnosis without biopsy or surgery. That matters because many benign liver lesions are harmless, stable, and best left alone.

Most benign liver lesions are found by chance
Benign liver lesions are often incidental findings. A person may have imaging for abdominal pain, gallstones, trauma, cancer surveillance, or unrelated symptoms. The report then mentions a “lesion”, “mass”, “cyst”, or “focal abnormality” in the liver.
Common benign lesions include:
Simple liver cysts
Haemangiomas
Focal nodular hyperplasia
Hepatic adenomas
Focal fatty infiltration or focal fatty sparing
In determining the likely diagnosis, we have to take into account:
Age and general health
History of cancer
Liver disease, hepatitis, or cirrhosis
Symptoms such as pain, fever, weight loss, or jaundice
Blood tests, including liver function tests
The appearance of the lesion on imaging
Radiology usually gives the diagnosis
The aim is to determine whether the imaging features are 'classical' of a benign lesion or not.
Ultrasound is often the starting point
Ultrasound is widely available, does not use ionising radiation, and can identify simple cysts very well. A simple cyst usually has fluid features, thin walls, and no solid parts.
Ultrasound can also suggest a haemangioma, especially when the appearance is classic.
CT helps define enhancement patterns
A CT scan performed with intravenous contrast ('dye') can show how a lesion behaves as contrast moves through the blood vessels and liver tissue. This is useful because many benign lesions have recognizable enhancement patterns.
For example, a haemangioma often fills in gradually with contrast. A lesion that follows this classic pattern may not need further tests.
MRI is often the problem-solving test
MRI gives excellent soft tissue detail and avoids ionizing radiation. It can be especially useful when CT or ultrasound is uncertain.
MRI with liver-specific contrast can help distinguish focal nodular hyperplasia from hepatic adenoma. That distinction matters because focal nodular hyperplasia is usually left alone, while some adenomas need closer management.

The problem with MRI is the cost. Outpatient MRI scans of the liver in Australia only attract a Medicare rebate (and thus reduced cost for patient) when there are specific criteria met (for example, a history of chronic liver disease or a primary cancer not arising from the liver) and are referred by a specialist (as opposed to your GP). So for patients with benign liver lesions that don't meet the criteria, there is a significant cost. This is made more confusing in that not all radiology practices that have MRI scanners have 'Medicare-eligible' MRI machines (for the current list, go to https://www.health.gov.au/topics/diagnostic-imaging/mri-and-pet-locations/mri-nsw).
The common lesions have different treatments
Benign liver lesions are not all managed the same way. The imaging diagnosis guides the plan.
Simple liver cysts rarely need intervention
A simple cyst is a fluid-filled space. Most cause no symptoms and do not become cancerous. If a cyst is large, causes pressure symptoms, has ruptured or become infected, treatment may be necessary, often involving minimally invasive surgery.
Complex cysts - those with thick walls, solid areas, internal nodules (lumps), or infection-like features (caused by certain parasites) will require thorough evaluation and possible surgery.
Haemangiomas are common vascular lesions
A liver haemangioma is a cluster of blood vessels. Many are small and silent. Once imaging shows typical features, treatment is usually unnecessary.
Surgery is rarely needed. It may be discussed if the haemangioma is very large, clearly causing symptoms, growing in a concerning way, or has uncertain imaging features after proper assessment.
Focal nodular hyperplasia is usually left alone
Focal nodular hyperplasia, often called FNH, is a benign overgrowth of normal liver elements. It is commonly found in people who feel well.
MRI can often identify FNH with high confidence, especially when a central scar or typical liver-specific contrast behaviour is seen. Once confirmed, FNH usually needs no treatment and may not need ongoing surveillance.
Hepatic adenoma needs more individualized care
Hepatic adenoma is benign, but it receives more attention than many other benign liver lesions because some adenomas can bleed or, rarely, transform into cancer.
Risk depends on factors such as:
Size
Growth over time
Imaging subtype
Sex assigned at birth and hormonal factors
Use of oestrogen-containing medication or anabolic steroids
Background metabolic conditions
Management may include stopping contributing hormones where medically appropriate, weight management when relevant, repeat MRI, or consideration for liver surgery.
Surgery is still not automatic. It is usually reserved for lesions with higher-risk features, larger adenomas, growth despite conservative steps, bleeding, or diagnostic uncertainty.
Biopsy and surgery are not the default
A liver biopsy can be helpful in selected cases, but it is not the first answer for every benign-appearing lesion. If imaging is classic, biopsy may add risk without changing care. Some vascular lesions, such as haemangiomas, are generally not biopsied due to the risk of bleeding.
Surgery is also uncommon for benign liver lesions. Some operations carry more risk than the lesion itself. The decision should balance symptoms, imaging certainty, lesion behaviour, and the person’s wider health.
The safest plan is often watchful confidence, not passive neglect. That means having enough imaging evidence to be comfortable, and avoiding unnecessary procedures.
A practical approach after a liver lesion is found
A clear pathway can help to reduce anxiety and unnecessary treatment.
Typically, this may be to:
Confirm whether the lesion has classic benign features.
Review risk factors, symptoms, and perform specific blood tests (liver function tests, hepatitis serology, tumour markers)
Use MRI if ultrasound or CT is inconclusive.
Compare with previous scans if available.
Referral to a specialist for evaluation - this often occurs earlier as specialist-referred MRI requests are required if there is any potential rebate from Medicare.
The right scan at the right time often answers the question. Benign liver lesions do not all need follow-up, and they rarely need surgery. The main goal is accurate diagnosis, monitoring when needed, and treatment only when the benefits clearly outweigh the risks.
Comments